Data on TMPRSS2-ERG and AR-V7 may pave the way for personalised therapy for prostate cancer (PCa) patients. Comprehensive molecular profiling can help identify multiple PCa subtypes and driving alterations. Translating these findings into clinical practice is still challenging.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eururo.2015.05.041 | DOI Listing |
Publication Analysis
Top Keywords
prostate cancer
8
current histopathologic
4
histopathologic molecular
4
molecular characterisations
4
characterisations prostate
4
cancer individualised
4
individualised prognosis
4
prognosis therapies
4
therapies data
4
data tmprss2-erg
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!